BIOSPACE BODY COMPOSITION ANALYZERS, MODEL INBODY 230

Analyzer, Body Composition

BIOSPACE CORPORATION LIMITED

The following data is part of a premarket notification filed by Biospace Corporation Limited with the FDA for Biospace Body Composition Analyzers, Model Inbody 230.

Pre-market Notification Details

Device IDK062603
510k NumberK062603
Device Name:BIOSPACE BODY COMPOSITION ANALYZERS, MODEL INBODY 230
ClassificationAnalyzer, Body Composition
Applicant BIOSPACE CORPORATION LIMITED PO BOX 7007 Deerfield,  IL  60015
ContactDaniel Kamm
CorrespondentDaniel Kamm
BIOSPACE CORPORATION LIMITED PO BOX 7007 Deerfield,  IL  60015
Product CodeMNW  
CFR Regulation Number870.2770 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2006-09-01
Decision Date2007-02-15
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.